The effectiveness of anti-TNF-  therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists

(2009) Federico Navarro-Sarabia et al.   BMC MUSCULOSKELETAL DISORDERS

Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational study

(2009) Clifton O. Bingham et al.   CURRENT MEDICAL RESEARCH AND OPINION

Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions

(2009) Robert M Plenge et al.   CURRENT OPINION IN RHEUMATOLOGY

Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan

(2009) T. KOIKE et al.   JOURNAL OF RHEUMATOLOGY

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

(2008) Arie E. van der Bijl et al.   CLINICAL RHEUMATOLOGY

Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis

(2008) Karin Laas et al.   CLINICAL RHEUMATOLOGY

Unknown

(2008) Chunyu Liu et al.   MOLECULAR MEDICINE

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug

(2008) K. L. Hyrich et al.   RHEUMATOLOGY

NICE guidelines on anti-tumor necrosis factor therapy for RA

(2008) David L Scott et al.   Nature clinical practice. Rheumatology